
51 - 200 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor being evaluated in breast and prostate cancer trials. The company advances a focused pipeline aimed at delivering transformative, targeted cancer treatments and conducts clinical development and data-driven research to support regulatory and medical adoption.
🕒 4 days ago
Commercial biotechnology supply-planning leader overseeing S&OP, inventory, procurement, and supplier forecasts. Ensuring continuous supply for Celcuity’s targeted cancer therapies.
🕒 6 days ago
Commercial supply operations leader supporting Celcuity’s oncology drug manufacturing and global supply chain. Driving compliant production planning, launches, external partnerships, and supply processes.
🕒 August 20
Associate Director leading drug safety and pharmacovigilance for Celcuity’s targeted cancer therapies. Overseeing clinical safety operations, vendors, regulatory reporting, and inspection readiness.
🕒 August 18
Oncology Sales Specialist executing Celcuity’s commercial strategy for targeted cancer therapies. Managing oncology territories, provider relationships, patient access, and product commercialization.
🕒 August 13
Senior Director leading biostatistics for Celcuity, a biotechnology company developing targeted therapies for solid tumors. Overseeing oncology trial design, analysis, reporting, and regulatory deliverables.
🕒 August 12
Pharmaceutical development leader overseeing small-molecule formulation, scale-up, technology transfer, and CDMO operations. Supporting Celcuity’s targeted cancer therapies and global regulatory submissions.